On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Cance1
Last Tuesday, 15 October 2024, IDIBAPS received a visit from thirty people, most of them patients with liver cancer under treatment at the Hospital C1
The Biobank makes more than 863,000 samples from over 56,000 different donors available to internal and external researchers.
The Catalan Tumour Bank Network (XBTC) has renewed its corporate identity and website to project a more dynamic and local network in the biomedicine1
Last Tuesday, 10 October 2023, IDIBAPS received a visit from a dozen patients with liver cancer under treatment at the Hospital Clínic. The aim was t1
The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various servic1
It currently contains a conservation fund of more than 250,000 nervous tissue samples that allows researchers to study a wide range of neurodegenerat1
The visit forms part of the knowledge exchange activities between institutions participating in the STEPUPIORS European project.
On Tuesday, 17 January 2023, the IDIBAPS auditorium was the venue for the Second Conference on Good Practice of the Network of Tumour Banks of Catalo1
ISO 9001 Quality Management System Requirements is the nationally and internationally recognized quality standard based on continuous process improve1
